No Data
Leadman: First quarter report 2025
Beijing Leadman Biochemistry (300289.SZ) released its first-quarter performance, reporting a net loss attributable to shareholders of 1.2517 million yuan, a decrease of 53.73%.
Beijing Leadman Biochemistry (300289.SZ) released the first quarter report for 2025, with the company's revenue amounting to 7890....
Leadman: 2024 Annual Report Summary
Leadman: 2024 Annual Report
Beijing Leadman Biochemistry (300289.SZ) announced its 2024 performance, reporting a loss of 75.1013 million yuan.
Beijing Leadman Biochemistry (300289.SZ) released its annual report for 2024, reporting a revenue of 0.37 billion yuan, and...
Beijing Leadman Biochemistry (300289.SZ) has been re-certified as a high-tech enterprise.
Gelonghui reported on February 11 that Beijing Leadman Biochemistry (300289.SZ) announced that it recently received the "High-tech Enterprise Certificate" jointly issued by the Peking Municipal Science and Technology Commission, the Peking Municipal Finance Bureau, and the State Taxation Administration's Peking Taxation Bureau. The company has once again passed the qualification for high-tech enterprises, with the certificate number GS202411000092, issued on December 19, 2024, and is valid for three years.